|
"yen cj"的相關文件
顯示項目 16-40 / 99 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2021-11-20 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study
|
Chiu, TJ;Su, YY;Yang, SH;Li, CP;Bai, LY;Chiang, NJ;Chuang, SC;Shan, YS;Chan, DC;Chen, LT;Yen, CJ;Peng, CM;Chen, YY;Chen, JS;Chou, WC |
| 國家衛生研究院 |
2021-11-12 |
The prognostic and predictive role of chromogranin a in gastroenteropancreatic neuroendocrine tumors - A single-center experience
|
Tsai, HJ;Hsiao, CF;Chang, JS;Chen, LT;Chao, YJ;Yen, CJ;Shan, YS |
| 國家衛生研究院 |
2021-07-15 |
No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol
|
Shan, YS;Chen, LT;Wu, CH;Chang, YF;Lee, CT;Chiang, NJ;Chao, YJ;Yen, CJ;Tsai, HJ;Huang, HE;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2021-06-12 |
Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers
|
Chang, KY;Chiang, NJ;Wu, SY;Yen, CJ;Chen, SH;Yeh, YM;Li, CF;Feng, XX;Wu, K;Johnston, A;Bomalaski, JS;Wu, BW;Gao, JJ;Subudhi, SK;Kaseb, AO;Blando, JM;Yadav, SS;Szlosarek, PW;Chen, LT |
| 國家衛生研究院 |
2021-05-04 |
Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
|
Huang, CC;Su, YC;Chang, CC;Lee, WT;Ou, CY;Wu, YH;Wu, SY;Lai, YH;Huang, JS;Chen, KC;Hsueh, WT;Tsai, ST;Yen, CJ;Chang, JY;Tsai, ML;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Hsiao, JR;Chang, JS |
| 國家衛生研究院 |
2021-01-21 |
Metformin resensitizes sorafenib-resistant HCC cells through AMPK-dependent autophagy activation
|
Lai, HY;Tsai, HH;Yen, CJ;Hung, LY;Yang, CC;Ho, CH;Liang, HY;Chen, FW;Li, CF;Wang, JM |
| 國家衛生研究院 |
2021-01 |
Metformin resensitizes sorafenib-resistant HCC cells through AMPK-dependent autophagy activation
|
Lai, HY;Tsai, HH;Yen, CJ;Hung, LY;Yang, CC;Ho, CH;Liang, HY;Chen, FW;Li, CF;Wang, JM |
| 中山醫學大學 |
2021 |
Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients' experience within a population-based study
|
Chiu, TJ; Su, YY; Yang, SH; Li, CP; Bai, LY; Chiang, NJ; Chuang, SC; Shan, YS; Chan, DC; Chen, LT; Yen, CJ; Peng, CM; Chen, YY; Chen, JS; Chou, WC |
| 國家衛生研究院 |
2020-11-27 |
Phase I dose-escalation study of SCB01A, a microtubule inhibitor with vascular disrupting activity, in patients with advanced solid tumors
|
Shiah, HS;Chiang, NJ;Lin, CC;Yen, CJ;Tsai, HJ;Wu, SY;Su, WC;Chang, KY;Wang, CC;Chang, JY;Chen, LT |
| 國家衛生研究院 |
2020-11-13 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort [Erraturm: Scientific Reports. 2020 May 4;10:Article number 7420.]
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-08 |
Investigating the health disparities in the association between lifestyle behaviors and the risk of head and neck cancer
|
Hsiao, JR;Huang, CC;Ou, CY;Chang, CC;Lee, WT;Tsai, ST;Huang, JS;Chen, KC;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2020-05-28 |
Multicentre, phase II study of gemcitabine and S-1 in patients with advanced biliary tract cancer: TG1308 study
|
Chiang, NJ;Chen, MH;Yang, SH;Hsu, C;Yen, CJ;Tsou, HH;Su, YY;Chen, JS;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-05-26 |
Validation of genome-wide association study-identified single nucleotide polymorphisms in a case-control study of pancreatic cancer from Taiwan
|
Shan, YS;Chen, LT;Wu, JS;Chang, YF;Lee, CT;Wu, CH;Chiang, NJ;Huang, HE;Yen, CJ;Chao, YJ;Tsai, HJ;Chen, CY;Kang, JW;Kuo, CF;Tsai, CR;Weng, YL;Yang, HC;Liu, HC;Chang, JS |
| 國家衛生研究院 |
2020-05-04 |
The impact of liposomal irinotecan on the treatment of advanced pancreatic adenocarcinoma: Real-world experience in a Taiwanese cohort
|
Su, YY;Chiang, NJ;Tsai, HJ;Yen, CJ;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2020-04 |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
de Bono, J;Lin, CC;Chen, LT;Corral, J;Michalarea, V;Rihawi, K;Ong, M;Lee, JH;Hsu, CH;Yang, JC;Shiah, HS;Yen, CJ;Anthoney, A;Jove, M;Buschke, S;Fuertig, R;Schmid, U;Goeldner, RG;Strelkowa, N;Huang, DC;Bogenrieder, T;Twelves, C;Cheng, AL |
| 國家衛生研究院 |
2020-03-10 |
Dishevelled 1-regulated superpotent cancer stem cells mediate wnt heterogeneity and tumor progression in hepatocellular carcinoma
|
Liao, WY;Hsu, CC;Chan, TS;Yen, CJ;Chen, WY;Pan, HW;Tsai, KK |
| 國家衛生研究院 |
2020-03-01 |
A selective Aurora-A 5'-UTR siRNA inhibits tumor growth and metastasis
|
Lai, CH;Chen, RY;Hsieh, HP;Tsai, SJ;Chang, KC;Yen, CJ;Huang, YC;Liu, YW;Lee, JC;Lai, YC;Hung, LY;Lin, BW |
| 國家衛生研究院 |
2020-03 |
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: A TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO
|
Chen, LT;Martinelli, E;Cheng, AL;Pentheroudakis, G;Qin, S;Bhattacharyya, GS;Ikeda, M;Lim, HY;Ho, GF;Choo, SP;Ren, Z;Malhotra, H;Ueno, M;Ryoo, BY;Kiang, TC;Tai, D;Vogel, A;Cervantes, A;Lu, SN;Yen, CJ;Huang, YH;Chen, SC;Hsu, C;Shen, YC;Tabernero, J;Yen, Y;Hsu, CH;Yoshino, T;Douillard, JY |
| 中山醫學大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, JS; Hsieh, RK; Chen, JS; Lee, KD; Rau, KM; Shao, YY; Sung, YC; Yeh, SP; Chang, CS; Liu, TC; Wu, MF; Lee, MY; Yu, MS; Yen, CJ; Lai, PY; Hwang, WL; Chiou, TJ |
| 國家衛生研究院 |
2019-10-05 |
Percutaneous computed tomography-guided coaxial core biopsy for the diagnosis of pancreatic tumors
|
Su, YY;Liu, YS;Chao, YJ;Chiang, NJ;Yen, CJ;Tsai, HM |
| 國家衛生研究院 |
2019-04-12 |
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer
|
Hsiao, JR;Lee, WT;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-04 |
Oral hygiene and the overall survival of head and neck cancer patients
|
Chang, CC;Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
| 國家衛生研究院 |
2019-01-12 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial
|
Yen, CJ;Tsou, HH;Hsieh, CY;Chu, CY;Chiu, CF;Chen, CC;Tsao, CJ;Tsai, KY;Tsai, ST;Chang, JY;Chang, KY |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-10-01 |
The influence of pre-diagnosis alcohol consumption and the polymorphisms of ethanol metabolizing genes on the survival of head and neck cancer patients
|
Lee, WT;Hsiao, JR;Ou, CY;Huang, CC;Chang, CC;Tsai, ST;Chen, KC;Huang, JS;Wong, TY;Lai, YH;Wu, YH;Hsueh, WT;Wu, SY;Yen, CJ;Chang, JY;Lin, CL;Weng, YL;Yang, HC;Chen, YS;Chang, JS |
顯示項目 16-40 / 99 (共4頁)
1 2 3 4 > >>
每頁顯示[10|25|50]項目
|
